Seminar Series: Alexander Peidl, PhD Candidate “CCN3: A novel anti-fibrotic therapy that targets the activation of collagen-lineage fibroblasts in a murine model of scleroderma”
Seminar Series: Alexander Peidl, PhD Candidate “CCN3: A novel anti-fibrotic therapy that targets the activation of collagen-lineage fibroblasts in a murine model of scleroderma”
